2,4-thiazolidinedione has been researched along with Dilatation, Pathologic in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, WH | 1 |
| Francis, GS | 1 |
| Hoogwerf, BJ | 1 |
| Young, JB | 1 |
1 other study available for 2,4-thiazolidinedione and Dilatation, Pathologic
| Article | Year |
|---|---|
Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure.
Topics: Adult; Aged; Ascites; Diabetes Complications; Diabetes Mellitus; Dilatation, Pathologic; Edema; Fema | 2003 |